CHA Biotech Co. Ltd (085660) — Cash Flow Quality Index
CHA Biotech Co. Ltd (085660) has a Cash Flow Quality Index of -4.10x as of March 2026. Operating cash flow of ₩-64.01 Billion is below net income of ₩15.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore CHA Biotech Co. Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CHA Biotech Co. Ltd Cash Flow Quality Index (2009–2019)
Historical Cash Flow Quality Index for CHA Biotech Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CHA Biotech Co. Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CHA Biotech Co. Ltd (2009–2019)
Year-by-year earnings quality comparison for CHA Biotech Co. Ltd. For live market cap and the full company financial profile, see 085660 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.54x | ₩25.24 Billion | ₩46.37 Billion | ▼ -82.4% |
| 2018 | 3.09x | ₩75.38 Billion | ₩24.39 Billion | ▲ +649.9% |
| 2016 | 0.41x | ₩11.29 Billion | ₩27.40 Billion | ▲ +145.8% |
| 2014 | -0.90x | ₩-2.57 Billion | ₩2.85 Billion | ▼ -134.5% |
| 2013 | 2.61x | ₩66.35 Billion | ₩25.45 Billion | ▲ +39.3% |
| 2012 | 1.87x | ₩45.77 Billion | ₩24.45 Billion | ▼ -78.3% |
| 2011 | 8.64x | ₩34.69 Billion | ₩4.02 Billion | ▲ +4.9% |
| 2010 | 8.24x | ₩42.07 Billion | ₩5.11 Billion | ▲ +86.6% |
| 2009 | 4.41x | ₩24.02 Billion | ₩5.44 Billion | — |